330 related articles for article (PubMed ID: 29684743)
1. Neuroendocrine neoplasms of rectum: A management update.
Bertani E; Ravizza D; Milione M; Massironi S; Grana CM; Zerini D; Piccioli AN; Spinoglio G; Fazio N
Cancer Treat Rev; 2018 May; 66():45-55. PubMed ID: 29684743
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathologic characteristics and prognosis of rectal neuroendocrine neoplasms].
Liu T; Liu P; Wu T; Pan Y; Chen G; Wang P; Jiang Y; Wu Y; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1015-1019. PubMed ID: 28900992
[TBL] [Abstract][Full Text] [Related]
3. [Endoscopic Treatment Outcome of Rectal Neuroendocrine Tumors Removed by Ligation-assisted Endoscopic Submucosal Resection].
Gu MG; Lee SH
Korean J Gastroenterol; 2018 Sep; 72(3):128-134. PubMed ID: 30270594
[TBL] [Abstract][Full Text] [Related]
4. Advantage of endoscopic mucosal resection with a cap for rectal neuroendocrine tumors.
Park SB; Kim HW; Kang DH; Choi CW; Kim SJ; Nam HS
World J Gastroenterol; 2015 Aug; 21(31):9387-93. PubMed ID: 26309365
[TBL] [Abstract][Full Text] [Related]
5. A tailored approach for endoscopic treatment of small rectal neuroendocrine tumor.
Heo J; Jeon SW; Jung MK; Kim SK; Shin GY; Park SM; Ahn SY; Yoon WK; Kim M; Kwon YH
Surg Endosc; 2014 Oct; 28(10):2931-8. PubMed ID: 24853847
[TBL] [Abstract][Full Text] [Related]
6. Incidental diagnosis of very small rectal neuroendocrine neoplasms: when should endoscopic submucosal dissection be performed? A single ENETS centre experience.
Pagano N; Ricci C; Brighi N; Ingaldi C; Pugliese F; Santini D; Campana D; Mosconi C; Ambrosini V; Casadei R
Endocrine; 2019 Jul; 65(1):207-212. PubMed ID: 30919286
[TBL] [Abstract][Full Text] [Related]
7. Cap-assisted EMR for rectal neuroendocrine tumors: comparisons with conventional EMR and endoscopic submucosal dissection (with videos).
Yang DH; Park Y; Park SH; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yang SK
Gastrointest Endosc; 2016 May; 83(5):1015-22; quiz 1023-.e6. PubMed ID: 26460225
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment and prognosis of gastric neuroendocrine neoplasms: a single-center experience.
Shen C; Chen H; Chen H; Yin Y; Han L; Chen J; Tang S; Yin X; Zhou Z; Zhang B; Chen Z
BMC Gastroenterol; 2016 Sep; 16(1):111. PubMed ID: 27613657
[TBL] [Abstract][Full Text] [Related]
9. Long-term prognosis of an endoscopically treated rectal neuroendocrine tumor: 10-year experience in a single institution.
Sung HY; Kim SW; Kang WK; Kim SY; Jung CK; Cho YK; Park JM; Lee IS; Choi MG; Chung IS
Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):978-83. PubMed ID: 22647741
[TBL] [Abstract][Full Text] [Related]
10. Treatment outcomes of endoscopic resection for rectal carcinoid tumors: an analysis of the resectability and long-term results from 46 consecutive cases.
Kaneko H; Hirasawa K; Koh R; Kobayashi R; Kokawa A; Tanaka K; Maeda S
Scand J Gastroenterol; 2016 Dec; 51(12):1489-1494. PubMed ID: 27687741
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors of patients with gastroenteropancreatic neuroendocrine neoplasms.
Huang PY; Tsai KL; Liang CM; Tai WC; Rau KM; Wu KL; Huang CC; Chuah SK
Kaohsiung J Med Sci; 2018 Nov; 34(11):650-656. PubMed ID: 30392572
[TBL] [Abstract][Full Text] [Related]
13. The ENETS TNM staging and grading system accurately predict prognosis in patients with rectal NENs.
Capurso G; Gaujoux S; Pescatori LC; Panzuto F; Panis Y; Pilozzi E; Terris B; de Mestier L; Prat F; Rinzivillo M; Coriat R; Coulevard A; Delle Fave G; Ruszniewski P
Dig Liver Dis; 2019 Dec; 51(12):1725-1730. PubMed ID: 31405587
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Endoscopic Resection for Rectal Neuroendocrine Tumors Smaller than 15 mm.
Hamada Y; Tanaka K; Mukai K; Baba Y; Kobayashi M; Tominaga S; Kawabata H; Sawai S; Kaneko M; Sugimoto S; Inoue H; Mimuro M; Tamaru S; Nakagawa H
Dig Dis Sci; 2023 Jul; 68(7):3148-3157. PubMed ID: 37024740
[TBL] [Abstract][Full Text] [Related]
15. Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas.
Tang LH; Untch BR; Reidy DL; O'Reilly E; Dhall D; Jih L; Basturk O; Allen PJ; Klimstra DS
Clin Cancer Res; 2016 Feb; 22(4):1011-7. PubMed ID: 26482044
[TBL] [Abstract][Full Text] [Related]
16. Clinical Outcomes of Patients with Small Rectal Neuroendocrine Tumors Treated Using Endoscopic Submucosal Resection with a Ligation Device.
Takita M; Sakai E; Nakao T; Kimoto Y; Ishii R; Konishi T; Ueno S; Kanda K; Negishi R; Muramoto T; Hashimoto H; Morikawa T; Matsuhashi N; Ohata K
Digestion; 2019; 99(1):72-78. PubMed ID: 30554202
[TBL] [Abstract][Full Text] [Related]
17. [Endoscopic therapy for gastroduodenal neuroendocrine neoplasms].
Maasberg S; Jürgensen C; Scheerer F; Pschowski R; Felder S; Begum N; Wiedenmann B; Pascher A; Pape UF
Chirurg; 2016 Apr; 87(4):271-9. PubMed ID: 26960437
[TBL] [Abstract][Full Text] [Related]
18. [Neuroendocrine neoplasms : Two families with distinct features unified in one classification (German version)].
Klöppel G
Pathologe; 2019 May; 40(3):211-219. PubMed ID: 30969346
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic treatments for rectal neuroendocrine tumors smaller than 16 mm: a meta-analysis.
Zhang HP; Wu W; Yang S; Lin J
Scand J Gastroenterol; 2016 Nov; 51(11):1345-53. PubMed ID: 27367942
[TBL] [Abstract][Full Text] [Related]
20. Patterns of Lymph Node Metastasis in Patients With T1/T2 Gastroduodenal Neuroendocrine Neoplasms: Implications for Endoscopic Treatment.
Zhou YJ; Wang QW; Zhang QW; Chen JN; Wang XY; Gao YJ; Li XB
Front Endocrinol (Lausanne); 2021; 12():658392. PubMed ID: 34122337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
